ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,538.80
-1.35%
S&P ASX All Technology
2,920.90
-1.38%
Brent Oil
89.455
3.52%
US Dollar vs AUD
1.56624
0.62%
Bitcoin
61,212.87
-3.62%
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Amgen Inc (AMGN)

  7. Amgen Inc (AMGN) News

AMGN Amgen Inc

263.05
-1.02 (-0.39%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Amgen Inc AMGN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-1.02 -0.39% 263.05 09:13:19
Open Price Low Price High Price Close Price Previous Close
265.47 262.58 265.92 262.75 264.07
more quote information »

Recent News

Date Time Source Heading
17/4/202407:26PRNUSAMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024
10/3/202404:20PRNUSAMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) AT AAD..
09/3/202409:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202409:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202409:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202409:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202409:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202409:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202409:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202409:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202409:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202409:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202408:00PRNUSAMGEN ANNOUNCES 2024 SECOND QUARTER DIVIDEND
01/3/202408:00PRNUSAMGEN TO PRESENT AT THE 44TH ANNUAL TD COWEN HEALTH CARE..
27/2/202401:00PRNUSAMGEN OPENS STATE-OF-THE-ART BIOMANUFACTURING SITE IN..
20/2/202408:00PRNUSAMGEN TO HOST CONFERENCE CALL ON RARE DISEASE
15/2/202408:23EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
13/2/202411:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202408:00PRNUSAMGEN TO PRESENT AT THE 34TH ANNUAL OPPENHEIMER HEALTHCARE..
07/2/202421:49IHMARKETNEWSMoody’s Downgrades NYCB to Junk Status, Ford Declares..
07/2/202409:05IHMARKETNEWSU.S. Stocks Finish Choppy Trading Day Modestly Higher
07/2/202408:20EDGAR2Form 8-K - Current report
07/2/202408:01PRNUSAMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL..
06/2/202422:27IHMARKETNEWSUS Index Futures Mixed, Oil Prices Edge Higher
03/2/202408:25IHMARKETNEWSU.S. Stocks Extend Thursday’s Rally On Upbeat Meta, Amazon..
02/2/202408:00PRNUSAMGEN ANNOUNCES WEBCAST OF 2023 FOURTH QUARTER AND FULL YEAR..
29/1/202421:00PRNCAdeCODE genetics: A sequence variant that increases risk of..
17/1/202422:33IHMARKETNEWSWall Street Highlights: Tesla Cuts Prices in Germany,..
11/1/202402:12DJNXeris Biopharma Shares Climb 12% on Amgen License Agreement
11/1/202400:53DJNXeris Biopharma Reaches License Agreement With Amgen On..
11/1/202400:45IHNWGLP-1: Beyond Diabetes, a Blockbuster Horizon Beckons
04/1/202408:00PRNUSAMGEN TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE..
03/1/202403:42DJNAmgen On Pace for Record High Close -- Data Talk
27/12/202301:00PRNUSAMGEN PROVIDES REGULATORY UPDATE ON STATUS OF LUMAKRAS®..
20/12/202312:38EDGAR2Form 3 - Initial statement of beneficial ownership of..
15/12/202301:53DJNAmgen Names James Bradner Chief Scientific Officer
15/12/202301:16EDGAR2Form 8-K - Current report
15/12/202301:00PRNUSAMGEN ANNOUNCES EXECUTIVE APPOINTMENTS TO ACCELERATE..
14/12/202321:00PRNUSAMGEN TO SPONSOR THE IRISH OPEN
14/12/202308:40DJNAmgen Gets FDA Priority Review For Lung Cancer Treatment
14/12/202308:00PRNUSFDA Grants Priority Review to Amgen's Tarlatamab Application..
13/12/202322:30IHMARKETNEWSCal-Maine Avian Flu Outbreak Impact, Amgen Hikes Dividend..
13/12/202308:41DJNAmgen Raises Dividend 5.6% To $2.25 A Share
13/12/202308:00PRNUSAMGEN ANNOUNCES 2024 FIRST QUARTER DIVIDEND INCREASE TO..
09/12/202301:00PRNUSAMGEN HIGHLIGHTS HEMATOLOGY PORTFOLIO AT ASH 2023
05/12/202311:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202311:40EDGAR2Form 144 - Report of proposed sale of securities
30/11/202312:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/11/202308:00PRNUSAMGEN TO PRESENT AT THE EVERCORE ISI HEALTHCONX CONFERENCE
14/11/202312:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

NASDAQ
AMGN
Amgen
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved